Sex differences in circulating and renal angiotensins of hypertensive mRen(2). Lewis but not normotensive Lewis rats.
Sex differences in blood pressure are evident in experimental models and human subjects, yet the mechanisms underlying this disparity remain equivocal. The current study sought to define the extent of male-female differences in the circulating and tissue renin-angiotensin aldosterone systems (RAASs) of congenic mRen(2). Lewis and control Lewis rats. Male congenics exhibited higher systolic blood pressure than females [200 +/- 4 vs. 146 +/- 7 mmHg, P < 0.01] or Lewis males and females [113 +/- 2 vs. 112 +/- 2 mmHg, P > 0.05]. Plasma ANG II levels were twofold higher in male congenics [47 +/- 3 vs. 19 +/- 3 pM, P < 0.01] and fivefold higher than in male or female Lewis rats [6 +/- 1 vs. 6 +/- 1 pM]. ANG I levels were also highest in the males; however, plasma ANG-(1-7) was higher in female congenics. Male congenics exhibited greater circulating renin and angiotensin-converting enzyme (ACE) activities, as well as angiotensinogen, than female littermates. Renal cortical and medullary ANG II levels were also higher in the male congenics versus all the other groups; ANG I was lower in the males. Cortical ACE2 activity was higher in male congenics, yet neprilysin activity and protein were greater in the females, which may contribute to reduced renal levels of ANG II. These data reveal that sex differences in both the circulating and renal RAAS are apparent primarily in the hypertensive group. The enhanced activity of the RAAS in male congenics may contribute to the higher pressure and tissue injury evident in the strain.
Pendergrass
Karl D
KD
Hypertension & Vascular Disease Ctr., Wake Forest Univ. Health Sciences, Winston-Salem, NC 27157-1095, USA.
Pirro
Nancy T
NT
Westwood
Brian M
BM
Ferrario
Carlos M
CM
Brosnihan
K Bridget
KB
Chappell
Mark C
MC
D000803:Angiotensin I / Q000378:metabolism; D000804:Angiotensin II / Q000378:metabolism; D000085962:Angiotensin-Converting Enzyme 2; D000808:Angiotensinogen / Q000378:metabolism; D000809:Angiotensins / Q000097:blood / Q000378:metabolism*; D000818:Animals; D030801:Animals, Genetically Modified; D001794:Blood Pressure; D004195:Disease Models, Animal; D005260:Female; D006973:Hypertension / Q000235:genetics / Q000378:metabolism* / Q000503:physiopathology; D007668:Kidney / Q000201:enzymology / Q000378:metabolism*; D008297:Male; D051379:Mice; D009206:Myocardium / Q000378:metabolism; D015260:Neprilysin / Q000378:metabolism; D010446:Peptide Fragments / Q000378:metabolism; D007703:Peptidyl-Dipeptidase A / Q000378:metabolism; D051381:Rats; D011917:Rats, Inbred Lew; D012083:Renin / Q000097:blood* / Q000235:genetics; D012084:Renin-Angiotensin System; D012737:Sex Factors
D000809:Angiotensins; D010446:Peptide Fragments; C473112:Ren2 protein, mouse; D000808:Angiotensinogen; D000804:Angiotensin II; D000803:Angiotensin I; D007703:Peptidyl-Dipeptidase A; C000705307:ACE2 protein, human; C000705328:Ace2 protein, mouse; C000705329:Ace2 protein, rat; D000085962:Angiotensin-Converting Enzyme 2; D012083:Renin; D015260:Neprilysin; C118790:angiotensin I (1-7)